1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €3.02 (-83.03%). The median is €3.02 (-83.03%).
| Buy |
3 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Mar 2026 | |
|---|---|---|
| Revenue | 1.85M | 40.71% |
| Gross profit | 927.83K | 44.42% |
| Net profit | -5.95M | 122.58% |
| EBITDA | -5.43M | 127.34% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €33.29M |
Number of shares | 2.43M |
52-week high/low | €22.92 - €2.36 |
| Dividends | No |
Beta | 0.82 |
P/E ratio | - |
PEG ratio | - |
P/B ratio | - |
P/S ratio | - |
Company profile
| Name | Ekso Bionics Holdings |
| CEO | Scott G. Davis |
| Employees | 53 |
Discover assets
Shareholders of Ekso Bionics Holdings also invest in the following assets
